# Molecular PharmaGroup – FDA Inspection, Aug 11, 2025

Source: https://www.keypedia.com/records/fda_inspections/molecular-pharmagroup/970503e4-df94-4018-a388-f7a3f0943923
Source feed: FDA_Inspections

> FDA inspection 1278107 of Molecular PharmaGroup, August 11, 2025. Classification: Voluntary Action Indicated (VAI). 3 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1278107
- Company Name: Molecular PharmaGroup
- Inspection Date: 2025-08-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: New Jersey District Office
- Citation Count: 3

## Related Documents

- [FDA Inspection 1224590 - 2023-12-11](https://www.keypedia.com/records/fda_inspections/molecular-pharmagroup/77871794-9244-4db7-ad18-46ed42d4d7ed)

## Related Officers

- [Amatul H. Marium](https://www.keypedia.com/people/amatul-h-marium/5db400ce-ffde-4310-82f8-766fd2458a4d)
- [Investigator](https://www.keypedia.com/people/annet-r-rajan/81b5a458-094f-48a5-839d-5c47b1a7c259)
- [Investigator](https://www.keypedia.com/people/stephenie-m-ortiz/b0923b14-b153-4893-8eb2-f5e6b1fd2041)

Company: https://www.keypedia.com/companies/molecular-pharmagroup/284f8e5d-cf64-49a4-80cb-59cd24428b20

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248
